Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Oropharyngeal Neoplasms 1Neoplasms 1Nasopharyngeal Neoplasms 1Mouth Neoplasms 1Lymphoid Interstitial Pneumonia 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Head and Neck Neoplasms 1

Interventions

pembrolizumab 6Cisplatin 6Magnetic Resonance Spectroscopy 5Specimen Handling 4Radiotherapy 3Radiation 3Nivolumab 3Fluorouracil 3Biopsy 3Surveys and Questionnaires 2Radiosurgery 2Paclitaxel 2Chemoradiotherapy 2Cetuximab 22-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a 2zimberelimab 1toripalimab 1temsirolimus 1peposertib 1nabiximols 1motexafin gadolinium 1mogamulizumab 1ipatasertib 1dl1520 1camrelizumab 1brodalumab 1belinostat 1apatinib 1advexin 1Valproic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Mouth Neoplasms × dl1520 × Clear all
NCT00006106 2013-07-10

ONYX-015 With Cisplatin and Fluorouracil in Treating Patients With Advanced Head and Neck Cancer

National Cancer Institute (NCI)

Phase 1 Withdrawn
Head & Neck

Lymphoid Interstitial Pneumonia, Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Neoplasms, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡